Aaron Dane
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Surgery 16
- Lipoproteins and Cardiovascular Health 12
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 12
- Co-authors
- Paul Martin (9 shared papers)Mike J. Warwick (9 shared papers)Dennis W. Schneck (9 shared papers)Ali Raza (3 shared papers)Steve Hill (1 shared paper)P. J. Phillips (1 shared paper)Eva M. Lenz (1 shared paper)Mireille Cantarini (2 shared papers)
- Journals
- Open Forum Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Pharmaceutical Statistics (5 papers)Clinical Infectious Diseases (4 papers)The Journal of Clinical Pharmacology (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Aaron Dane
54 papers receiving 1.9k citations
Aaron Dane's Hit Papers
Peers
Comparison fields: 5 of 127
- Applied Microbiology and Biotechnology 143
- Molecular Medicine 365
- Pharmacology 166
- Pharmacology 311
- Surgery 561
Countries citing papers authored by Aaron Dane
This map shows the geographic impact of Aaron Dane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Dane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Dane more than expected).
Fields of papers citing papers by Aaron Dane
This network shows the impact of papers produced by Aaron Dane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Dane. The network helps show where Aaron Dane may publish in the future.
Co-authors
The 25 scholars most cited alongside Aaron Dane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 241 | |
| 2 | 2019 | 110 | |
| 3 | 2001 | 107 | |
| 4 | 2013 | 99 | |
| 5 | 2002 | 96 | |
| 6 | 2003 | 91 | |
| 7 | 2002 | 80 | |
| 8 | 2003 | 79 | |
| 9 | 2003 | 78 | |
| 10 | Cefepime–Taniborbactam in Complicated Urinary Tract Infection Hit paper breakdown → | 2024 | 78 |
| 11 | 2002 | 64 | |
| 12 | 2022 | 59 | |
| 13 | 2000 | 57 | |
| 14 | 2018 | 53 | |
| 15 | 2003 | 48 | |
| 16 | 2017 | 48 | |
| 17 | 2003 | 47 | |
| 18 | 2002 | 44 | |
| 19 | 2021 | 42 | |
| 20 | 2019 | 39 |
About Aaron Dane
Aaron Dane is a scholar working on Surgery, Pharmacology, Epidemiology, Infectious Diseases and Molecular Medicine, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Lipoproteins and Cardiovascular Health (12 papers), Antibiotic Resistance in Bacteria (8 papers), Urinary Tract Infections Management (6 papers), Statistical Methods in Clinical Trials (6 papers), Migraine and Headache Studies (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (143 citations), Molecular Medicine (365 citations), Pharmacology (166 citations), Pharmacology (311 citations) and Surgery (561 citations). Aaron Dane has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul Martin, Mike J. Warwick, Dennis W. Schneck, Ali Raza, Steve Hill, P. J. Phillips, Eva M. Lenz, Mireille Cantarini, John Rex and John Kemp. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Pharmaceutical Statistics, Clinical Infectious Diseases and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.